ATE281840T1 - Behandlung von diarrhoe - Google Patents

Behandlung von diarrhoe

Info

Publication number
ATE281840T1
ATE281840T1 AT97926891T AT97926891T ATE281840T1 AT E281840 T1 ATE281840 T1 AT E281840T1 AT 97926891 T AT97926891 T AT 97926891T AT 97926891 T AT97926891 T AT 97926891T AT E281840 T1 ATE281840 T1 AT E281840T1
Authority
AT
Austria
Prior art keywords
animal
diarrhea
reuteri
patient
cells
Prior art date
Application number
AT97926891T
Other languages
English (en)
Inventor
Ivan A Casas
Bo Mollstam
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Application granted granted Critical
Publication of ATE281840T1 publication Critical patent/ATE281840T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97926891T 1996-06-05 1997-06-03 Behandlung von diarrhoe ATE281840T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/658,473 US5837238A (en) 1996-06-05 1996-06-05 Treatment of diarrhea
PCT/US1997/009626 WO1997046104A1 (en) 1996-06-05 1997-06-03 Treatment of diarrhea

Publications (1)

Publication Number Publication Date
ATE281840T1 true ATE281840T1 (de) 2004-11-15

Family

ID=24641378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97926891T ATE281840T1 (de) 1996-06-05 1997-06-03 Behandlung von diarrhoe

Country Status (12)

Country Link
US (1) US5837238A (de)
EP (1) EP0923293B1 (de)
JP (2) JP2000512634A (de)
AT (1) ATE281840T1 (de)
AU (1) AU734194B2 (de)
BR (1) BR9710689A (de)
CA (1) CA2257077C (de)
DE (1) DE69731540T2 (de)
ES (1) ES2232869T3 (de)
PL (1) PL189998B1 (de)
PT (1) PT923293E (de)
WO (1) WO1997046104A1 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US6399055B1 (en) * 1998-10-27 2002-06-04 Compagnie Gervais Danone Method and composition for treatment of infant diarrhea
EP1034787A1 (de) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactobacillus Stämme die gegen pathogenische Bacteria veranlassende Diarrhöe schutzen
EP1034788A1 (de) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Milchsäure Bakterienstämme zur Verhinderung von Diarrhöe
RO121700B1 (ro) * 1999-03-11 2008-02-28 Societe Des Produits Nestle S.A. Bacterii lactobacillus capabile să prevină diareea cauzată de bacterii patogene şi rotavirusuri
US6283294B1 (en) * 1999-09-01 2001-09-04 Biogaia Biologics Ab Enclosed living cell dispensing tube
US6746672B2 (en) 2000-06-19 2004-06-08 Regents Of The University Of Minnesota Isolated bifidobacteria that produce siderophores which inhibit growth of lactococcus lactis
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
KR100437497B1 (ko) * 2001-03-07 2004-06-25 주식회사 프로바이오닉 로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제
US20040071793A1 (en) * 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
US7105336B2 (en) 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
US7517681B2 (en) * 2003-01-29 2009-04-14 Biogaia Ab Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
US20050281756A1 (en) * 2004-06-14 2005-12-22 Eamonn Connolly Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
AU2004285450B2 (en) 2003-10-20 2010-01-14 Gregory K. Frykman Zeolite molecular sieves for the removal of toxins
US7955834B2 (en) 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US20060078546A1 (en) * 2004-10-07 2006-04-13 Anders Zachrisson Use of lactic acid bacteria to reduce sick time
US7344867B2 (en) * 2005-04-15 2008-03-18 Eamonn Connolly Selection and use of lactic acid bacteria for reducing inflammation in mammals
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US8603460B2 (en) * 2006-06-05 2013-12-10 Brogaia AB Method of making a Lactobacillus reuteri with increased acid tolerance
US7374924B2 (en) 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis
EP1997499A1 (de) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mikroorganismen aus der Muttermilch, Zusammensetzungen, die diese enthalten und deren Verwendung zur Behandlung von Mastitis
US8617537B2 (en) 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
US20110014324A1 (en) * 2009-07-10 2011-01-20 Christoffer Lundqvist Product for the storage of freeze-dried lactic acid bacteria mixed with oral rehydration solution
EP4663746A3 (de) 2010-02-01 2026-04-15 Ferring Microbiome Inc. Bakterientherapie für clostridium-difficile-colitis
US20110293710A1 (en) 2010-02-02 2011-12-01 Delphine Saulnier Immunomodulatory properties of lactobacillus strains
IT1401460B1 (it) * 2010-06-11 2013-07-26 Probiotical Spa "ceppi di batteri probiotici produttori di vitamina b12"
JP2010280664A (ja) * 2010-07-02 2010-12-16 Biogaia Ab ラクトバチルス・リューテリ(Lactobacillusreuteri)株を用いる哺乳類における免疫機能の改善方法
CA2807242C (en) 2010-08-04 2017-05-02 Thomas Julius Borody Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
BR112013022927A2 (pt) 2011-03-09 2016-12-06 Univ Minnesota composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
US20130022586A1 (en) 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
GB201206599D0 (en) 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
CN104684565A (zh) * 2012-05-29 2015-06-03 达努塔·克鲁谢夫斯卡 在人类和兽医的预防和医疗中有用的、包含罗伊氏乳杆菌dan080的纳米产品及其医疗用途
EP2674162A1 (de) * 2012-05-29 2013-12-18 Danuta Kruszewska Nanoprodukt, beinhaltend lactobacillus reuteri dan080, zur verwendung bei der prophylaxe, diagnose sowie bei der medizinischen and veterinärmedizinischen behandlung
KR102099503B1 (ko) 2013-06-05 2020-04-09 리바이오틱스, 인코퍼레이티드 미생물상 복원 요법(mrt) 조성물
US10716850B2 (en) 2014-12-31 2020-07-21 Wellin, Inc. Anti-inflammatory factor retentate, method of isolation, and use
CN114159476A (zh) 2015-05-14 2022-03-11 克雷斯顿沃控股公司 用于粪便菌群移植的组合物以及用于制备和使用它们的方法和用于递送它们的装置
CN114366759A (zh) 2015-05-22 2022-04-19 亚利桑那大学董事会 用于治疗自闭症谱系障碍及相关症状的方法
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
WO2018187464A1 (en) 2017-04-05 2018-10-11 Crestovo Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3606541A1 (de) 2017-04-05 2020-02-12 Crestovo Holdings LLC Zusammensetzungen und verfahren zur behandlung der parkinson-krankheit (pd) und verwandten erkrankungen
CN110996917A (zh) 2017-05-26 2020-04-10 克雷斯顿沃控股公司 包含基于粪便微生物的治疗剂的冻干组合物及其制造和使用方法
KR20200038506A (ko) 2017-08-07 2020-04-13 핀치 테라퓨틱스, 인코포레이티드 건강한 장 장벽을 유지 및 회복시키기 위한 조성물 및 방법
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
CN113164527A (zh) 2018-09-27 2021-07-23 芬奇治疗控股有限责任公司 用于治疗癫痫和相关障碍的组合物和方法
WO2021016081A1 (en) 2019-07-19 2021-01-28 Finch Therapeutics Holdings Llc. Methods and products for treatment of gastrointestinal disorders
WO2024081219A1 (en) 2022-10-14 2024-04-18 Csp Technologies, Inc. Container and method for storing and stabilizing moisture sensitive products
WO2024102831A2 (en) * 2022-11-09 2024-05-16 The Cleveland Clinic Foundation Modulation of the gut microbiome for enhancement of gut and brain health

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3582180D1 (de) * 1984-02-09 1991-04-25 Royal Children S Hospital Rese Lebender attenuierter menschlicher rotavirus-impfstoff und herstellung desselben.
AU5791586A (en) * 1985-05-29 1986-12-04 Pioneer Hi-Bred International, Inc. Treating gastro-intestinal disease in animals
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
FI895197A0 (fi) * 1987-05-01 1989-11-01 Probiologics Int Inc Antibiotikum reuterin.
US5480641A (en) * 1990-06-15 1996-01-02 Biogaia Ab Feed additive which consists of whey and Lactobacillus reuteri and a method of delivering Lactobacillus reuteri to the gastrointestinal tract
JPH05292947A (ja) * 1992-04-17 1993-11-09 Sanei Touka Kk ラクトバチルス・アシドフィルスpn−ri−2−4、それを用いた乳酸菌製剤及びその製造方法
DE69627994D1 (de) * 1995-12-21 2003-06-12 Biogaia Ab Stockholm Verwendung von lactobacillus reuteri zur hemmung der kryptosporidiosis in säugetieren

Also Published As

Publication number Publication date
WO1997046104A1 (en) 1997-12-11
PT923293E (pt) 2005-03-31
DE69731540D1 (de) 2004-12-16
AU734194B2 (en) 2001-06-07
DE69731540T2 (de) 2005-10-27
EP0923293A1 (de) 1999-06-23
JP2000512634A (ja) 2000-09-26
PL189998B1 (pl) 2005-10-31
EP0923293A4 (de) 2001-11-07
JP2010265303A (ja) 2010-11-25
BR9710689A (pt) 1999-08-17
ES2232869T3 (es) 2005-06-01
EP0923293B1 (de) 2004-11-10
US5837238A (en) 1998-11-17
AU3154897A (en) 1998-01-05
JP4861500B2 (ja) 2012-01-25
PL330324A1 (en) 1999-05-10
CA2257077A1 (en) 1997-12-11
CA2257077C (en) 2008-10-07

Similar Documents

Publication Publication Date Title
DE69731540D1 (de) Behandlung von diarrhoe
AU579595B2 (en) Enzyme-resistant immunomodulatory peptides
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
GEP20002146B (en) Therapeutic Peptide Derivatives
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
MX340738B (es) Terapia para deficiencia de a-galactosidasa a.
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE68915834D1 (de) Herstellung von T-Zellen und T-Zellmembranen, verwendbar zur Verhütung und Behandlung von Autoimmunkrankheiten.
DE69434218D1 (de) Photodynamische behandlung von synovium
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
NO961478D0 (no) Levobupivacaine anvendelig for kontroll av kronisk smerte
DE69631478D1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
ATE291918T1 (de) Kombinationstherapie zur behandlung von tumoren
ATE234614T1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ATE180277T1 (de) Zur behandlung von tumoren und hiv-infektionen nützliches pflanzliches protein
GEP20012511B (en) Method for Lowering Level of Lipoproteins (a) in Serum or Plasma of Mammals, Method for Treatment of Peripheral Vascular Diseases or Restenosis
UA39179C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб
AU4042795A (en) Treatment of non-small cell lung carcinoma
EP0321094A3 (de) Behandlung von Faktor-VIII-Inhibitoren
UA7955A (uk) Спосіб лікування туберкульозу легенів
GEP19981480B (en) Method for Treating Vertebral Column
UA10281C2 (uk) Спосіб отримання речовини для лікування захворювань підшлункової залози
UA10230A (uk) Спосіб лікування хронічного обструктивного бронхіту

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0923293

Country of ref document: EP